Michael Maitland, M.D.

Member

Dr. Maitland is an internationally recognized authority in early-phase clinical trial design, pharmacokinetics, Project Optimus, and regulatory strategy. He currently serves as Vice President for Clinical Development at Pathos and previously served as Medical Lead for CRISPR technologies at Intellia Therapeutics. A respected physician-scientist and member of the ASCO Cancer Research Committee, Dr. Maitland brings extensive expertise in advancing innovative oncology therapies through clinical development and regulatory strategy.